Kyntra Bio Gross Margin Growth & History (KYNB)

Kyntra Bio's gross margin was 91.37% for fiscal 2025.

View full Kyntra Bio company overview

Kyntra Bio annual gross margin history

Kyntra Bio annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3191.37%+43.90 pp
20242024-12-3147.47%−44.07 pp
20232023-12-3191.53%+5.94 pp
20222022-12-3185.59%−8.94 pp
20212021-12-3194.53%−0.44 pp
20202020-12-3194.97%−4.58 pp
20192019-12-3199.55%

Kyntra Bio gross margin trends

Over the last five fiscal years, Kyntra Bio's gross margin decreased from 94.97% to 91.37%, a change of −3.60 percentage points. The latest reported quarter, Q1 2026, shows −9.84%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Kyntra Bio source filings ↗

Community posts

It’s quiet here.

No posts about KYNB yet. Start the conversation.

Write the first post